HPM Partners »

Intra Cellular Therapies shares owned by HPM Partners

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by HPM Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.4M 34k 69.20
2023-12-31 $266k 3.7k 71.62

More positions owned by HPM Partners

Vanguard Index Fds Stock (VOO)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Procter And Gamble Stock (PG)
Spdr S&p 500 Etf Tr Equities (SPY)
Ishares Tr Ex Trd Eq Fd (IVV)
Nvidia Corporation Stock (NVDA)
Vanguard Tax-managed Fds Equities (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Credit Accep Corp Mich Stock (CACC)
Eli Lilly & Co Equities (LLY)
Alphabet Equities (GOOGL)
Ishares Tr Stock (QUAL)
Alphabet Equities (GOOG)

View all positions for HPM Partners

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Daniel D. Thurber
Bellevue Group
venBio Select Advisor
Geode Capital Management
Alliancebernstein
Wellington Management Company
Jpmorgan Chase & Co
ClearBridge Advisors
Franklin Resources
Jennifer Ranahan
T. Rowe Price Associates
Avidity Partners Management

View all funds holding Intra Cellular Therapies